Europe has faced an unprecedented challenge related to drug shortages. Previously, shortages were dictated by production capacity & changing market. However, the largely inflationary-driven negative impact on pharma developers seen in 2023 has continued into 2024 as manufacturers battle with high operating costs while govts continue to curb price growth through cost-containment policies.
Open FlipReported Consolidated quarterly numbers for TVS Srichakra are: Net Sales at Rs 841.74 crore in September 2024 up 13.8% from Rs. 739.65 crore in September 2023. Quarterly Net Profit at Rs. 10.31 crore in September 2024 down 73.65% from Rs. 39.12 crore in September 2023. EBITDA stands at Rs. 61.43 crore in September 2024 down 32.72% from Rs. 91.31 crore in September 2023.
Open FlipShalimar Paints reported a 21.49% increase in net sales to Rs 144.74 crore in September 2024, but incurred a net loss of Rs 19.62 crore, up 23.42% from the same period last year, with a negative EBITDA of Rs 11.44 crore. Shalimar Paints shares have given -35.67% returns over the last 6 months and -41.34% over the last 12 months.
Open Flip